Newsletters

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, CMS, HUD, and DOT. Plus other notable actions by FHWA, ISB, DOE, EPA, and HHS.

With opinions and analysis from Bjorn Lomborg, Rochelle Toplensky, Richard Morrison, Ross Douthat, Roger Ballentine, Sarah Wall, Paul Kupiec, Susan Ness, Chris Riley, Drew Kershen, Henry Miller, Daniel Takash, Robby Soave, Eugene Volokh, and others.

Plus news from New York Times, Wall Street Journal, The HIll, Associated Press, Washington Post, Los Angeles Times, Washington Examiner, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS and FEMA. Plus other notable actions by NHTSA, FDA, FCC, DHS, EPA, and FERC.

With opinions and analysis from Adam Thierer, Gerard Baker, Harvey Pitt, Mairead McGuinness, Shane Tews, Patrick Hedger, Jared Schoreder, John Ruple, Jamie Pleune, Isaac Brown, Robert Martin, Henry Miller, Andrew Fillat, Kevin Williamson, Stephen Mihm, Bill Greenwalt, Dustin Walker, Brent Orrell, Matthew Mitchell, and others.

Plus news from Reuters, New York Times, Associated Press, Wall Street Journal, The Hill, Vox, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, DHS, and GEO. Plus other notable actions by NTIA, NMFS, OPM, and President Biden.

With opinions and analysis from Steven Balla, Huang Chen, Yat To Yeung, Tyler Cowen, James Broughel, Travis Nix, Allysia Finley, Vivek Ramaswamy, Amrita Kulka, Caroline Cecot, James Taranto, Vasant Dhar, Jonathan Turley, William Dudley, Cary Coglianese, Alicia Lai, Anne Junod, Heidi Shierholz, Randy May, and others.

Plus news from Reuters, New York Times, Associated Press, Wall Street Journal, The Hill, Politico, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the CDC and FDA. Plus other notable actions by CEQ, FDA, SEC, and EPA.

With opinions and analysis from Richard Pierce, Allysia Finley, Binyamin Appelbaum, Devin Hartman, Hannah Druckenmiller, Paul Kupiec, Ilya Somin, Stephen Carter, Alison Somin, Patrick Gleason, Anne Finucane, Robert Litan, and others.

Plus news from Axios, The Hill, New York Times, Government Executive, Wall Street Journal, Associated Press, Politico, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by President Biden, CDC, and HHS. Plus other notable actions by SEC, DOE, CFPB, and HHS.

With opinions and analysis from Earl Baker, Peggy Noonan, Brian Blase, Crispin Sartwell, Peter Wallison, Andy Mukherjee, Elizabeth Rush, Pete Sepp, Howard Husock, Lindsey Stroud, Jamelle Bouie, Eli Lehrer, Yael Ossowski, and others.

Plus news from New York Times, Wall Street Journal, The Hill, Associated Press, Washington Post, CNBC, Reuters, E&E News, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the CDC. Plus other notable actions by the FDIC, EPA, Interior, and OSTP.

With opinions and analysis from Steve Balla, Bridget Dooling, Emily Hammond, Dylan Desjardins, Phil Gramm, Christine Wilson, James Broughel, Jonathan Adler, Eric Bolinder, Jason De Sena Trennert, Michelle Dhansinghani, Eswar Prasad, Steve Forbes, and others.

Plus news from Salon, New York Times, Wall Street Journal, Time, E&E News, Associated Press, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by ED, FEMA, PTO, Treasury, and NRC. Plus other notable actions by EPA, DHS, OSHA, OSTP, NHTSA, SEC, and DOT.

With opinions and analysis from Diane Katz, James Mackintosh, Margaret Renkl, Rupert Darwall, Peter Coy, Jason Hill, William Shughart, Wayne Crews Jon Markman, Edwart Pinto, Tobias Peter, Sara Barth, Richard Epstein, Vinay Prasad, Xavier D'Haultfoeuille, Ed Dolan, Jonathan Adler, Veronique de Rugy, Toshiaki Takigawa, Bill Funk, Jessica Melugin, and others.

Plus news from CNBC, New York Times, Associated Press, Wall Street Journal, The Hill, Politico, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by OSHA, USDA, CDC, FDA, HUD, and HRSA. Plus other notable actions by DOL, SEC, OFCCP, DHS, and President Biden.

With opinions and analysis from Laura Stanley, Howard Beales, Todd Zywicki, Bernard Bell, Michael O'Reilly, Narayana Kocherlakota, Jason Riley, Hannah Wiseman, Timothy Fitzgerald, Kevin Hassett, Jay Clayton, Nir Kaissar, Oonagh McDonald, Kristin Tate, Alden Abbott, Andrew Mercado, James Broghel, Patrick McLaughlin, Aurelien Portuese, Julie Carlson, Richard Epstein, Sandra Aguilar-Gomez, Nydia Remolina, Sandra Oh, Randy May, and others.

Plus news from Utility Dive, New York Times, Associated Press, Wall Street Journal, The Hill, E&E News, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by DHS, FEMA, DOL, and FDA. Plus other notable actions by President Biden, FCC, FTC, SEC, and CEQ.

With opinions and analysis from Bridget Dooling, Ezra Klein, Tyler Cowen, Telis Demos, Paul Tice, Richard Morrison, Yevgeny Shrago, Diane Katz, Devin Watkins, Wayne Crews, Laura Figueroa, Emily Bremer, Jennifer Mascott, Henry Miller, Christopher Walker, Michelle Kumar, and Daniel Farber.

Plus news from New York Times, Associated Press, Wall Street Journal, NPR, The Hill, Reuters, Washington Post, and Bloomberg.

FULL NEWSLETTER

This update features a recent report by co-authored by Steve Balla and Bridget Dooling Mass, Computer-Generated, and Fraudulent Comments, for the Administrative Conference of the United States.  Dooling and Balla also joined Susan Dudley on the GW Trachtenberg School's summer conversation series to discuss the report and more: Mass, Bots, and Fake Comments on Rulemaking.

The update also includes research by Tara Sinclair and Zhoudan Xie on Sentiment and Uncertainty about Regulation, Mark Febrizio and Kekai Liu on The Frequency of Regulatory Suspensions in the 21st Century, commentary on President Biden's executive order on competition, distributional effects in regulatory impact analysis, equity in rulemaking, agency guidance documents, and antitrust enforcement..

Also featured is Bridget Dooling's selection by the Administrative Conference of the United States to work with Rachel Potter from the University of Virginia to study the use of contractors in the rulemaking process.

Plus various op-eds in Slate and Forbes, events with the Regulatory Transparency Project, Case Western University, Women in Government Relations, Environmental Protection Agency, and the ABA's AdLaw Section. Plus quotes in popular media outlets, including the Los Angeles Times, The Hill, and Yahoo.

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conference of the United States by Steve Balla and Bridget Dooling.

Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.

Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street Journal, NPR, Government Executive, Daily Beast, Marketplace, and Axios.

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street Journal, Federal News Network, Science, Bloomberg, USA Today, and Axios.

FULL NEWSLETTER

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street Journal, New York Times, The Hill, Bloomberg, Forbes, Politico, Reuters, Audubon Magazine, Government Executive, and Law360.

FULL NEWSLETTER

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.